GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Marketable Securities

AP Biosciences (ROCO:6945) Marketable Securities : NT$100.00 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. AP Biosciences's Marketable Securities for the quarter that ended in Dec. 2024 was NT$100.00 Mil.

AP Biosciences's annual Marketable Securities increased from Dec. 2022 (NT$30.71 Mil) to Dec. 2023 (NT$461.41 Mil) but then declined from Dec. 2023 (NT$461.41 Mil) to Dec. 2024 (NT$100.00 Mil).

AP Biosciences Marketable Securities Historical Data

The historical data trend for AP Biosciences's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences Marketable Securities Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Marketable Securities
- 30.00 30.71 461.41 100.00

AP Biosciences Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Marketable Securities Get a 7-Day Free Trial 30.71 462.28 461.41 100.00 100.00

AP Biosciences Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

AP Biosciences  (ROCO:6945) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

AP Biosciences Marketable Securities Related Terms

Thank you for viewing the detailed overview of AP Biosciences's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

AP Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Marketable Securities
Comparable Companies
TPE:6794 ROCO:1777 ROCO:3176 ROCO:6808 TPE:6838 ROCO:6986 ROCO:8279 ROCO:06891 ROCO:6733 ROCO:6864 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 17th Floor, Taipei, TWN
Website
https://www.apbioinc.com
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences Headlines

No Headlines